| Kathleen Mcbride, CRNA, FNP | |
|
6644 E Baywood Ave, Mesa, AZ 85206-1747 | |
| (480) 321-2000 | |
| Not Available |
| Full Name | Kathleen Mcbride |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 6644 E Baywood Ave, Mesa, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336344514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN039208 CRNA0039 (Arizona) | Primary |
| 363LF0000X | Nurse Practitioner - Family | RN039208 AP0867 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Mcbride, CRNA, FNP Po Box 1370, Hereford, AZ 85615-1370 Ph: (520) 378-2590 | Kathleen Mcbride, CRNA, FNP 6644 E Baywood Ave, Mesa, AZ 85206-1747 Ph: (480) 321-2000 |
News Archive
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.
Merz Pharma Group announced today that the subsequent offering period of the tender offer by Merz GmbH & Co. KGaA ("Merz") and its acquisition subsidiary to purchase all of the outstanding shares of common stock of BioForm Medical, Inc. at a price of $5.45 per share, net to the seller in cash (without interest thereon and less any required withholding tax) expired as scheduled at 12:00 midnight, Eastern Standard Time, on February 18, 2010.
A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu vaccine annually to match predicted strains, with major implications for global health.
› Verified 6 days ago
Aida E Amado, MS, ACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10163 E Jacob Ave, Mesa, AZ 85209 Phone: 480-296-8849 | |
Marilyn Rose Schatz, ACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, Suite 401, Mesa, AZ 85206 Phone: 480-835-7111 Fax: 480-969-9345 | |
Mrs. Krista Ann Roppelt, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3155 E Southern Ave Ste 203, Mesa, AZ 85204 Phone: 480-325-8173 Fax: 480-325-8179 | |
Alisha Kristine Holben, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 560 S Bellview, Mesa, AZ 85204 Phone: 276-623-7851 | |
Danielle Marin Hendrickson, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1303 S Longmore, Mesa, AZ 85202 Phone: 480-649-5297 | |
Mari Michelle Hooper, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 646 S Sabrina, Mesa, AZ 85208 Phone: 480-628-8370 | |
Mrs. Marguerite R Galindo, MS, FNP-C, RN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6015 E Brown Rd, Mesa, AZ 85205 Phone: 480-266-4436 |